Benitec Biopharma (BNTC) Q2 2026 Earnings

14MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.45
-0.37
-0.3
-0.22

Details

Expected EPS
-0.268333
Actual EPS
-0.24
Surprise EPS
0.03
Surprise Percent
+10.56%

Description

Benitec Biopharma (BNTC) has reported earnings of -0.24 per share for Q2 2026.

0 Comments

Share your thoughts